Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Mar-22 8:35 AM View:  | Giordano Natasha Chief Executive Officer Director | Plx Pharma Inc. (PLXP) | 15-Mar-22 | Private Purchase | 4,100 | $3.65 | $14,976.90 | 378% 1.09K to 5.19K | |
| 16-Mar-22 8:33 AM View: | O'Connor Rita M Chief Financial Officer | Plx Pharma Inc. (PLXP) | 15-Mar-22 | Private Purchase | 13,700 | $3.66 | $50,122.00 | 106% 12.97K to 26.67K | |
| 15-Jun-21 4:47 PM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 14-Jun-21 | Market Purchase | 8,000 | $12.48 | $99,870.40 | 2% 486.69K to 494.69K | (< 1%) |
| 09-Mar-21 5:06 PM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 05-Mar-21 | Market Purchase | 25,000 | $8.00 | $200,000.00 | 5% 461.69K to 486.69K | (11%) |
| 15-Dec-20 5:38 PM View: | Hadden John Director | Plx Pharma Inc. (PLXP) | 14-Dec-20 | Market Purchase | 1,000 | $5.45 | $5,447.96 | 37% 2.69K to 3.69K | 14% |
| 25-Nov-20 4:08 PM View: | Hadden John Director | Plx Pharma Inc. (PLXP) | 25-Nov-20 | Market Purchase | 500 | $5.48 | $2,737.85 | 23% 2.19K to 2.69K | 14% |
| 20-Nov-20 7:46 PM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 18-Nov-20 | Private Purchase | 264,900 | $3.79 | $1,003,180.00 | 135% 196.79K to 461.69K | |
| 03-Sep-20 8:49 AM View: | O'Connor Rita M Chief Financial Officer | Plx Pharma Inc. (PLXP) | 02-Sep-20 | Market Purchase | 2,120 | $3.83 | $8,126.60 | 20% 10.85K to 12.97K | 62% |
| 03-Sep-20 8:49 AM View: | O'Connor Rita M Chief Financial Officer | Plx Pharma Inc. (PLXP) | 01-Sep-20 | Market Purchase | 4,500 | $3.74 | $16,837.20 | 71% 6.35K to 10.85K | 66% |
| 24-Aug-20 9:12 AM View: | O'Connor Rita M Chief Financial Officer | Plx Pharma Inc. (PLXP) | 21-Aug-20 | Market Purchase | 4,050 | $3.97 | $16,090.70 | 176% 2.3K to 6.35K | 56% |
| 24-Aug-20 9:12 AM View: | O'Connor Rita M Chief Financial Officer | Plx Pharma Inc. (PLXP) | 20-Aug-20 | Market Purchase | 2,300 | $3.77 | $8,665.71 | 100% 0 to 2.3K | 65% |
| 21-May-19 6:20 PM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 20-May-19 | Market Purchase | 44,404 | $5.60 | $248,662.00 | 29% 152.39K to 196.79K | 12% |
| 31-Dec-18 4:41 PM View: | Park West Asset Management ... 10% Owner | Plx Pharma Inc. (PLXP) | 27-Dec-18 | Market Purchase | 397,495 | $1.00 | $397,495.00 | 37% 1.08M to 1.47M | 527% |
| 14-Aug-17 11:56 AM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 10-Aug-17 | Grant | 30,000 | -- | -- | 25% 122.39K to 152.39K | |
| 16-Jun-17 2:07 PM View: | Mossman Gary L Chief Operating Officer 10% Owner | Plx Pharma Inc. (PLXP) | 14-Jun-17 | Market Purchase | 7,273 | $6.88 | $50,001.90 | 8% 87.95K to 95.22K | (8%) |
| 16-Jun-17 2:14 PM View: | Jorden David Emerson Acting Chief Financial Officer 10% Owner | Plx Pharma Inc. (PLXP) | 14-Jun-17 | Market Purchase | 32,727 | $6.88 | $224,998.00 | 27% 119.19K to 151.91K | (8%) |
| 16-Jun-17 2:00 PM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 14-Jun-17 | Market Purchase | 29,091 | $6.88 | $200,001.00 | 31% 93.3K to 122.39K | (8%) |
| 20-Apr-17 9:15 PM View: | Casale Robert Director | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 2,710 | -- | -- | 100% 0 to 2.71K | |
| 20-Apr-17 9:16 PM View: | Jorden David Emerson Acting Chief Financial Officer | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 119,186 | -- | -- | 100% 0 to 119.19K | |
| 20-Apr-17 9:17 PM View: | Valentino Michael J Executive Chairman Director | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 93,295 | -- | -- | 100% 0 to 93.3K | |
| 20-Apr-17 9:14 PM View: | Balkema Gary S. Director | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 5,445 | -- | -- | 100% 0 to 5.45K | |
| 20-Apr-17 9:15 PM View: | Giordano Natasha President and CEO Director | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 1,086 | -- | -- | 100% 0 to 1.09K | |
| 20-Apr-17 9:17 PM View: | Mossman Gary L Chief Operating Officer | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 70,982 | -- | -- | 100% 0 to 70.98K | |
| 20-Apr-17 9:14 PM View: | Calhoun Kirk K Director | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 1,675 | -- | -- | 100% 0 to 1.68K | |
| 20-Apr-17 9:16 PM View: | Hadden John Director | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 2,190 | -- | -- | 100% 0 to 2.19K | |
| 20-Apr-17 9:17 PM View: | Mossman Gary L Chief Operating Officer | Plx Pharma Inc. (PLXP) | 19-Apr-17 | Grant | 16,964 | -- | -- | 24% 70.98K to 87.95K | |
| 22-May-14 5:38 PM View: | Dean Jack H Director | Plx Pharma Inc. (PLXP) | 21-May-14 | Market Purchase | 3,000 | $9.00 | $27,000.00 | 7% 45.92K to 48.92K | (93%) |
| 19-Mar-14 12:20 PM View: | Garrett David VP, Finance & Corp. Dev. | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 2,083 | $12.00 | $24,996.00 | 26% 7.92K to 10.01K | |
| 20-Mar-14 6:52 PM View: | Harrison Thomas L Director | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 2,000 | $12.00 | $24,000.00 | 1% 146.83K to 148.83K | |
| 19-Mar-14 12:20 PM View: | Luci David P President, CEO, Secretary Director 10% Owner | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 2,083 | $12.00 | $24,996.00 | < 1% 1.83M to 1.84M | |
| 20-Mar-14 6:52 PM View: | Dean Jack H Director | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 2,083 | $12.00 | $24,996.00 | 5% 43.83K to 45.92K | |
| 19-Mar-14 12:19 PM View: | Deluccia Robert J Executive Chairman Director 10% Owner | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 2,083 | $12.00 | $24,996.00 | < 1% 1.83M to 1.83M | |
| 19-Mar-14 12:20 PM View: | Shawah Robert G. Chief Accounting Officer | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 500 | $12.00 | $6,000.00 | 100% 0 to 0.5K | |
| 20-Mar-14 6:52 PM View: | Coughlin Christopher J Director | Plx Pharma Inc. (PLXP) | 18-Mar-14 | Purchase | 2,083 | $12.00 | $24,996.00 | 2% 107.23K to 109.31K |
